{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:22:21Z","timestamp":1793395341470,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKENHI","award":["JP16K11145"],"award-info":[{"award-number":["JP16K11145"]}]},{"name":"JSPS KAKENHI","award":["JP18K16806"],"award-info":[{"award-number":["JP18K16806"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Mol Morphol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00795-020-00273-3","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T07:03:03Z","timestamp":1609830183000},"page":"133-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Endometrial cancer with a POLE mutation progresses frequently through the type I pathway despite its high-grade endometrioid morphology: a cohort study at a single institution in Japan"],"prefix":"10.1007","volume":"54","author":[{"given":"Mahina","family":"Monsur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6091-7038","authenticated-orcid":false,"given":"Munekage","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Yoshinobu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chimeddulam","family":"Erdenebaatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Iwagoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ohba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Iyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Katabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"273_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1126\/science.1144067","volume":"317","author":"ZF Pursell","year":"2007","unstructured":"Pursell ZF, Isoz I, Lundstr\u00f6m EB, Johansson E, Kunkel TA (2007) Yeast DNA polymerase epsilon participates in leading-strand DNA replication. Science 317:127\u2013130","journal-title":"Science"},{"key":"273_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1634\/theoncologist.2017-0034","volume":"22","author":"E Castellucci","year":"2017","unstructured":"Castellucci E, He T, Goldstein DY, Halmos B, Chuy J (2017) DNA polymerase \u03b5 deficiency leading to an ultramutator phenotype: a novel clinically relevant entity. Oncologist 22:497\u2013502","journal-title":"Oncologist"},{"key":"273_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497:67\u201373","journal-title":"Nature"},{"key":"273_CR4","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1093\/hmg\/ddt131","volume":"22","author":"DN Church","year":"2013","unstructured":"Church DN, Briggs SE, Palles C, Domingo E, Kearsey SJ, Grimes JM, Gorman M, Martin L, Howarth KM, Hodgson SV, Collaborators NSECG, Kaur K, Taylor J, Tomlinson IP (2013) DNA polymerase \u03b5 and \u03b4 exonuclease domain mutations in endometrial cancer. Hum Mol Genet 22:2820\u20132828","journal-title":"Hum Mol Genet"},{"key":"273_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ygyno.2014.05.006","volume":"134","author":"B Meng","year":"2014","unstructured":"Meng B, Hoang LN, McIntyre JB, Duggan MA, Nelson GS, Lee CH, K\u00f6bel M (2014) POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium. Gynecol Oncol 134:15\u201319","journal-title":"Gynecol Oncol"},{"key":"273_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ygyno.2015.12.031","volume":"141","author":"A Wong","year":"2016","unstructured":"Wong A, Kuick CH, Wong WL, Tham JM, Mansor S, Loh E, Jain S, Vikas NN, Tan SH, Chan SH, Li ST, Chew SH, Hong W, Ngeow J (2016) Mutation spectrum of POLE and POLD1 mutations in south east asian women presenting with grade 3 endometrioid endometrial carcinomas. Gynecol Oncol 141:113\u2013120","journal-title":"Gynecol Oncol"},{"key":"273_CR7","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1158\/1078-0432.CCR-15-0057","volume":"21","author":"IC van Gool","year":"2015","unstructured":"van Gool IC, Eggink FA, Freeman-Mills L, Stelloo E, Marchi E, de Bruyn M, Palles C, Nout RA, de Kroon CD, Osse EM, Klenerman P, Creutzberg CL, Tomlinson IP, Smit VT, Nijman HW, Bosse T, Church DN (2015) POLE proofreading mutations elicit an antitumor immune response in endometrial cancer. Clin Cancer Res 21:3347\u20133355","journal-title":"Clin Cancer Res"},{"key":"273_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10\u201317","journal-title":"Gynecol Oncol"},{"key":"273_CR9","first-page":"177","volume":"150","author":"H Tashiro","year":"1997","unstructured":"Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L (1997) p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 150:177\u2013185","journal-title":"Am J Pathol"},{"key":"273_CR10","first-page":"228","volume":"81","author":"SF Lax","year":"1997","unstructured":"Lax SF, Kurman RJ (1997) A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Verh Dtsch Ges Pathol 81:228\u2013232","journal-title":"Verh Dtsch Ges Pathol"},{"key":"273_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13669-013-0074-3","volume":"3","author":"H Tashiro","year":"2014","unstructured":"Tashiro H, Katabuchi H (2014) The relationship between estrogen and genes in the molecular pathogenesis of endometrial carcinoma. Curr Obstet Gynecol Rep 3:9\u201317","journal-title":"Curr Obstet Gynecol Rep"},{"key":"273_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U","volume":"88","author":"SF Lax","year":"2000","unstructured":"Lax SF, Kendall B, Tashiro H, Slebos RJ, Hedrick L (2000) The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Cancer 88:814\u2013824","journal-title":"Cancer"},{"key":"273_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ygyno.2011.07.030","volume":"124","author":"MA Voss","year":"2012","unstructured":"Voss MA, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, Wei W, Sundar S (2012) Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation. Gynecol Oncol 124:15\u201320","journal-title":"Gynecol Oncol"},{"key":"273_CR14","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1200\/JCO.19.00151","volume":"37","author":"MA Clarke","year":"2019","unstructured":"Clarke MA, Devesa SS, Harvey SV, Wentzensen N (2019) Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers. J Clin Oncol 37:1895\u20131908","journal-title":"J Clin Oncol"},{"key":"273_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ygyno.2017.07.145","volume":"149","author":"CM Tarney","year":"2018","unstructured":"Tarney CM, Tian C, Wang G, Dubil EA, Bateman NW, Chan JK, Elshaikh MA, Cote ML, Schildkraut JM, Shriver CD, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM (2018) Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecol Oncol 149:12\u201321","journal-title":"Gynecol Oncol"},{"key":"273_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/jog.13863","volume":"45","author":"S Nagase","year":"2019","unstructured":"Nagase S, Ohta T, Takahashi F, Enomoto T (2019) Annual patients report for 2015 and annual treatment report for 2010. J Obstet Gynaecol Res 45:289\u2013298","journal-title":"J Obstet Gynaecol Res"},{"key":"273_CR17","doi-asserted-by":"publisher","first-page":"17093","DOI":"10.18632\/oncotarget.24907","volume":"9","author":"DS Guttery","year":"2018","unstructured":"Guttery DS, Blighe K, Polymeros K, Symonds RP, Macip S, Moss EL (2018) Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas. Oncotarget 9:17093\u201317103","journal-title":"Oncotarget"},{"key":"273_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ygyno.2017.12.009","volume":"149","author":"EA Dubil","year":"2018","unstructured":"Dubil EA, Tian C, Wang G, Tarney CM, Bateman NW, Levine DA, Conrads TP, Hamilton CA, Maxwell GL, Darcy KM (2018) Racial disparities in molecular subtypes of endometrial cancer. Gynecol Oncol 149:106\u2013116","journal-title":"Gynecol Oncol"},{"key":"273_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/path.5372","volume":"250","author":"A Le\u00f3n-Castillo","year":"2020","unstructured":"Le\u00f3n-Castillo A, Britton H, McConechy MK, McAlpine JN, Nout R, Kommoss S, Brucker SY, Carlson JW, Epstein E, Rau TT, Bosse T, Church DN, Gilks CB (2020) Interpretation of somatic POLE mutations in endometrial carcinoma. J Pathol 250:323\u2013335","journal-title":"J Pathol"},{"key":"273_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/PGP.0000000000000527","volume":"38","author":"C Erdenebaatar","year":"2019","unstructured":"Erdenebaatar C, Yamaguchi M, Monsur M, Saito F, Honda R, Tashiro H, Ohba T, Iyama KI, Katabuchi H (2019) Serum prolactin contributes to enhancing prolactin receptor and pJAK2 in type I endometrial cancer cells in young women without insulin resistance. Int J Gynecol Pathol 38:318\u2013325","journal-title":"Int J Gynecol Pathol"},{"key":"273_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jendso\/bvz029","volume":"4","author":"M Yamaguchi","year":"2020","unstructured":"Yamaguchi M, Erdenebaatar C, Saito F, Honda R, Ohba T, Kyo S, Tashiro H, Katabuchi H (2020) Prolactin enhances the proliferation of proliferative endometrial glandular cells and endometrial cancer cells. J Endocr Soc 4:1\u201313","journal-title":"J Endocr Soc"},{"issue":"Suppl 1","key":"273_CR22","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","volume":"38","author":"M K\u00f6bel","year":"2019","unstructured":"K\u00f6bel M, Ronnett BM, Singh N, Soslow RA, Gilks CB, McCluggage WG (2019) Interpretation of p53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility. Int J Gynecol Pathol 38(Suppl 1):S123\u2013S131","journal-title":"Int J Gynecol Pathol"},{"key":"273_CR23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/cas.12929","volume":"107","author":"K Ohnishi","year":"2016","unstructured":"Ohnishi K, Yamaguchi M, Erdenebaatar C, Saito F, Tashiro H, Katabuchi H, Takeya M, Komohara Y (2016) Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma. Cancer Sci 107:846\u2013852","journal-title":"Cancer Sci"},{"key":"273_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.12659\/MSCR.901499","volume":"3","author":"J Kido","year":"2016","unstructured":"Kido J, Mitsubuchi H, Itoh F, Yoshida T, Matsumoto S, Endo F, Nakamura F (2016) Advanced endometrial cancer in phenylketonuria. Med Sci Case Rep 3:108\u2013111","journal-title":"Med Sci Case Rep"},{"key":"273_CR25","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/cncr.29046","volume":"121","author":"CC Billingsley","year":"2015","unstructured":"Billingsley CC, Cohn DE, Mutch DG, Stephens JA, Suarez AA, Goodfellow PJ (2015) Polymerase \u025b (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing. Cancer 121:386\u2013394","journal-title":"Cancer"},{"key":"273_CR26","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1158\/1078-0432.CCR-15-2233","volume":"22","author":"MK McConechy","year":"2016","unstructured":"McConechy MK, Talhouk A, Leung S, Chiu D, Yang W, Senz J, Reha-Krantz LJ, Lee CH, Huntsman DG, Gilks CB, McAlpine JN (2016) Endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis. Clin Cancer Res 22:2865\u20132873","journal-title":"Clin Cancer Res"},{"key":"273_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ygyno.2016.11.023","volume":"144","author":"S Bellone","year":"2017","unstructured":"Bellone S, Bignotti E, Lonardi S, Ferrari F, Centritto F, Masserdotti A, Pettinella F, Black J, Menderes G, Altwerger G, Hui P, Lopez S, de Haydu C, Bonazzoli E, Predolini F, Zammataro L, Cocco E, Ferrari F, Ravaggi A, Romani C, Facchetti F, Sartori E, Odicino FE, Silasi DA, Litkouhi B, Ratner E, Azodi M, Schwartz PE, Santin AD (2017) Polymerase \u03b5 (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro. Gynecol Oncol 144:146\u2013152","journal-title":"Gynecol Oncol"},{"key":"273_CR28","doi-asserted-by":"publisher","first-page":"e0214318","DOI":"10.1371\/journal.pone.0214318","volume":"14","author":"S Imboden","year":"2019","unstructured":"Imboden S, Nastic D, Ghaderi M, Rydberg F, Rau TT, Mueller MD, Epstein E, Carlson JW (2019) Phenotype of POLE-mutated endometrial cancer. PLoS ONE 14:e0214318","journal-title":"PLoS ONE"},{"key":"273_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ygyno.2019.10.028","volume":"156","author":"M Stasenko","year":"2020","unstructured":"Stasenko M, Tunnage I, Ashley CW, Rubinstein MM, Latham AJ, Da Cruz PA, Mueller JJ, Leitao MM Jr, Friedman CF, Makker V, Soslow RA, DeLair DF, Hyman DM, Zamarin D, Alektiar KM, Aghajanian CA, Abu-Rustum NR, Weigelt B, Cadoo KA (2020) Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer. Gynecol Oncol 156:194\u2013202","journal-title":"Gynecol Oncol"},{"key":"273_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrg3051","volume":"12","author":"ZE Sauna","year":"2011","unstructured":"Sauna ZE, Kimchi-Sarfaty C (2011) Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 12:683\u2013691","journal-title":"Nat Rev Genet"},{"key":"273_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2008.05.042","volume":"134","author":"DA Drummond","year":"2008","unstructured":"Drummond DA, Wilke CO (2008) Mistranslation-induced protein misfolding as a dominant constraint on coding-sequence evolution. Cell 134:341\u2013352","journal-title":"Cell"},{"key":"273_CR32","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.01.051","volume":"156","author":"F Supek","year":"2014","unstructured":"Supek F, Mi\u00f1ana B, Valc\u00e1rcel J, Gabald\u00f3n T, Lehner B (2014) Synonymous mutations frequently act as driver mutations in human cancers. Cell 156:1324\u20131335","journal-title":"Cell"},{"key":"273_CR33","doi-asserted-by":"publisher","first-page":"26011","DOI":"10.1038\/srep26011","volume":"6","author":"K Yamaguchi","year":"2016","unstructured":"Yamaguchi K, Nagayama S, Shimizu E, Komura M, Yamaguchi R, Shibuya T, Arai M, Hatakeyama S, Ikenoue T, Ueno M, Miyano S, Imoto S, Furukawa Y (2016) Reduced expression of APC-1B but not APC-1A by the deletion of promoter 1B is responsible for familial adenomatous polyposis. Sci Rep 6:26011","journal-title":"Sci Rep"},{"key":"273_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ygyno.2019.03.098","volume":"153","author":"H Britton","year":"2013","unstructured":"Britton H, Huang L, Lum A, Leung S, Shum K, Kale M, Burleigh A, Senz J, Yang W, McConechy M, Kommoss S, Brucker S, Talhouk A, Gilks CB, McAlpine JN (2013) Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma. Gynecol Oncol 153:487\u2013495","journal-title":"Gynecol Oncol"},{"key":"273_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/his.12029","volume":"62","author":"RA Soslow","year":"2013","unstructured":"Soslow RA (2013) High-grade endometrial carcinomas\u2014strategies for typing. Histopathology 62:89\u2013110","journal-title":"Histopathology"},{"key":"273_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/jog.13459","volume":"44","author":"T Miyamoto","year":"2018","unstructured":"Miyamoto T, Ando H, Asaka R, Yamada Y, Shiozawa T (2018) Mutation analysis by whole exome sequencing of endometrial hyperplasia and carcinoma in one patient: Abnormalities of polymerase epsilon and the phosphatidylinositol-3 kinase pathway. J Obstet Gynaecol Res 44:179\u2013183","journal-title":"J Obstet Gynaecol Res"},{"issue":"Suppl 1","key":"273_CR37","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1097\/PGP.0000000000000491","volume":"38","author":"R Murali","year":"2019","unstructured":"Murali R, Davidson B, Fadare O, Carlson JA, Crum CP, Gilks CB, Irving JA, Malpica A, Matias-Guiu X, McCluggage WG, Mittal K, Oliva E, Parkash V, Rutgers JKL, Staats PN, Stewart CJR, Tornos C, Soslow RA (2019) High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations. Int J Gynecol Pathol 38(Suppl 1):S40\u2013S63","journal-title":"Int J Gynecol Pathol"},{"key":"273_CR38","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/his.12878","volume":"68","author":"S Bakhsh","year":"2016","unstructured":"Bakhsh S, Kinloch M, Hoang LN, Soslow RA, K\u00f6bel M, Lee CH, McAlpine JN, McConechy MK, Gilks CB (2016) Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy. Histopathology 68:916\u2013924","journal-title":"Histopathology"},{"key":"273_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/path.5081","volume":"245","author":"D Temko","year":"2018","unstructured":"Temko D, Van Gool IC, Rayner E, Glaire M, Makino S, Brown M, Chegwidden L, Palles C, Depreeuw J, Beggs A, Stathopoulou C, Mason J, Baker AM, Williams M, Cerundolo V, Rei M, Taylor JC, Schuh A, Ahmed A, Amant F, Lambrechts D, Smit VT, Bosse T, Graham TA, Church DN, Tomlinson I (2018) Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response. J Pathol 245:283\u2013296","journal-title":"J Pathol"},{"key":"273_CR40","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/modpathol.3800620","volume":"19","author":"M Reid-Nicholson","year":"2006","unstructured":"Reid-Nicholson M, Iyengar P, Hummer AJ, Linkov I, Asher M, Soslow RA (2006) Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. Mod Pathol 19:1091\u20131100","journal-title":"Mod Pathol"},{"key":"273_CR41","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/0046-8177(95)90204-X","volume":"26","author":"ME Sherman","year":"1995","unstructured":"Sherman ME, Bur ME, Kurman RJ (1995) p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 26:1268\u20131274","journal-title":"Hum Pathol"},{"key":"273_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/ajcp\/98.1.81","volume":"98","author":"ME Bur","year":"1992","unstructured":"Bur ME, Perlman C, Edelmann L, Fey E, Rose PG (1992) p53 expression in neoplasms of the uterine corpus. Am J Clin Pathol 98:81\u201387","journal-title":"Am J Clin Pathol"},{"key":"273_CR43","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","volume":"37","author":"CB Gilks","year":"2013","unstructured":"Gilks CB, Oliva E, Soslow RA (2013) Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma. Am J Surg Pathol 37:874\u2013881","journal-title":"Am J Surg Pathol"},{"key":"273_CR44","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/modpathol.2013.102","volume":"26","author":"G Han","year":"2013","unstructured":"Han G, Sidhu D, Duggan MA, Arseneau J, Cesari M, Clement PB, Ewanowich CA, Kalloger SE, K\u00f6bel M (2013) Reproducibility of histological cell type in high-grade endometrial carcinoma. Mod Pathol 26:1594\u20131604","journal-title":"Mod Pathol"},{"key":"273_CR45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/modpathol.2014.143","volume":"28","author":"YR Hussein","year":"2015","unstructured":"Hussein YR, Weigelt B, Levine DA, Schoolmeester JK, Dao LN, Balzer BL, Liles G, Karlan B, K\u00f6bel M, Lee CH, Soslow RA (2015) Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations. Mod Pathol 28:505\u2013514","journal-title":"Mod Pathol"},{"key":"273_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/path.5373","volume":"250","author":"A Le\u00f3n-Castillo","year":"2020","unstructured":"Le\u00f3n-Castillo A, Gilvazquez E, Nout R, Smit VT, McAlpine JN, McConechy M, Kommoss S, Brucker SY, Carlson JW, Epstein E, Rau TT, Soslow RA, Ganesan R, Matias-Guiu X, Oliva E, Harrison BT, Church DN, Gilks CB, Bosse T (2020) Clinicopathological and molecular characterisation of \u2018multiple-classifier\u2019 endometrial carcinomas. J Pathol 250:312\u2013322","journal-title":"J Pathol"}],"container-title":["Medical Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-020-00273-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00795-020-00273-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-020-00273-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T16:06:51Z","timestamp":1674835611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00795-020-00273-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1007\/s00795-020-00273-3","relation":{},"ISSN":["1860-1480","1860-1499"],"issn-type":[{"value":"1860-1480","type":"print"},{"value":"1860-1499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"13 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Complaince with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}